Standard Standard

Ultra-long acting pharmaceuticals: Do they result in better outcomes, and at an acceptable cost? / Hughes, D.; Hughes, D.A.

2006. Paper presented at 10th European Sympoisum on Patient Compliance and Persistence, Bonn, Germany, .

Research output: Contribution to conferencePaper

HarvardHarvard

Hughes, D & Hughes, DA 2006, 'Ultra-long acting pharmaceuticals: Do they result in better outcomes, and at an acceptable cost?' Paper presented at 10th European Sympoisum on Patient Compliance and Persistence, Bonn, Germany, 3/01/01, .

APA

Hughes, D., & Hughes, D. A. (2006). Ultra-long acting pharmaceuticals: Do they result in better outcomes, and at an acceptable cost?. Paper presented at 10th European Sympoisum on Patient Compliance and Persistence, Bonn, Germany, .

CBE

Hughes D, Hughes DA. 2006. Ultra-long acting pharmaceuticals: Do they result in better outcomes, and at an acceptable cost?. Paper presented at 10th European Sympoisum on Patient Compliance and Persistence, Bonn, Germany, .

MLA

VancouverVancouver

Hughes D, Hughes DA. Ultra-long acting pharmaceuticals: Do they result in better outcomes, and at an acceptable cost?. 2006. Paper presented at 10th European Sympoisum on Patient Compliance and Persistence, Bonn, Germany, .

Author

Hughes, D. ; Hughes, D.A. / Ultra-long acting pharmaceuticals: Do they result in better outcomes, and at an acceptable cost?. Paper presented at 10th European Sympoisum on Patient Compliance and Persistence, Bonn, Germany, .

RIS

TY - CONF

T1 - Ultra-long acting pharmaceuticals: Do they result in better outcomes, and at an acceptable cost?

AU - Hughes, D.

AU - Hughes, D.A.

PY - 2006/11/1

Y1 - 2006/11/1

M3 - Paper

ER -